Loading...

David Poch

TitleAssociate Clinical Professor
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9300 Campus Point Drive #7381
La Jolla CA 92037
Phone858-657-7150
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mahmud E, Madani MM, Kim NH, Poch D, Ang L, Behnamfar O, Patel MP, Auger WR. Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease. J Am Coll Cardiol. 2018 May 29; 71(21):2468-2486. PMID: 29793636.
      View in: PubMed
    2. Mahmud E, Behnamfar O, Ang L, Patel MP, Poch D, Kim NH. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Interv Cardiol Clin. 2018 Jan; 7(1):103-117. PMID: 29157517.
      View in: PubMed
    3. Herrero T, Martin E, Poch D, Roeder HA. Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension. J Matern Fetal Neonatal Med. 2018 May; 31(9):1209-1213. PMID: 28353362.
      View in: PubMed
    4. Fernandes TM, Poch D, Auger WR. Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty. Methodist Debakey Cardiovasc J. 2016 Oct-Dec; 12(4):205-212. PMID: 28289495.
      View in: PubMed
    5. Poch D. Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat. BMC Pulm Med. 2016 05 18; 16(1):82. PMID: 27193179; PMCID: PMC4870744.
    6. Poch D, Auger WR. Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes. Heart Fail Rev. 2016 05; 21(3):309-22. PMID: 26739298.
      View in: PubMed
    7. Lee NS, Blanchard DG, Knowlton KU, McDivit AM, Pretorius V, Madani MM, Fedullo PF, Kerr KM, Kim NH, Poch D, Auger WR, Daniels LB. Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension. Pulm Circ. 2015 Jun; 5(2):313-21. PMID: 26064456; PMCID: PMC4449242.
    8. Fernandes TM, Auger WR, Fedullo PF, Kim NH, Poch D, Madani MM, Pretorius VG, Jamieson SW, Kerr KM. Baseline body mass index does not significantly affect outcomes after pulmonary thromboendarterectomy. Ann Thorac Surg. 2014 Nov; 98(5):1776-81. PMID: 25240778; PMCID: PMC4254364.
    9. Xie Y, Burke BM, Kopelnik A, Auger W, Daniels LB, Madani MM, Poch D, Kim NH, Blanchard DG. Echocardiographic estimation of pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension: utility of right heart Doppler measurements. Echocardiography. 2014; 31(1):29-33. PMID: 23822605.
      View in: PubMed
    10. Mandel J, Poch D. In the clinic. Pulmonary hypertension. Ann Intern Med. 2013 May 07; 158(9):ITC5-1 -16. PMID: 23648959.
      View in: PubMed
    11. de Jesus Perez VA, Rosenzweig E, Rubin LJ, Poch D, Bajwa A, Park M, Jain M, Bourge RC, Kudelko K, Spiekerkoetter E, Liu J, Hsi A, Zamanian RT. Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension. Am J Cardiol. 2012 Nov 15; 110(10):1546-50. PMID: 22853986.
      View in: PubMed
    12. Ost DE, Poch D, Fadel A, Wettimuny S, Ginocchio C, Wang XP. Mini-bronchoalveolar lavage quantitative polymerase chain reaction for diagnosis of methicillin-resistant Staphylococcus aureus pneumonia. Crit Care Med. 2010 Jul; 38(7):1536-41. PMID: 20473148.
      View in: PubMed
    13. Poch D, Ost DE. What are the important risk factors for healthcare-associated pneumonia? Semin Respir Crit Care Med. 2009 Feb; 30(1):26-35. PMID: 19199184.
      View in: PubMed